Novel Therapeutic Targets for the Treatment of Tubulointerstitial Fibrosis
Jai Prakash(Radboud University Nijmegen), Robbert J. Kok(Utrecht University), Harry van Goor(University Medical Center Groningen), Klaas Poelstra(University of Groningen), Frits Moolenaar(University of Groningen), Dirk Meijer(University of Groningen)
Cited by 6
Related Papers
RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature
|Drug Resistance Updates|2005|461
Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status
|Advanced Drug Delivery Reviews|2013|396
Criteria for definition of a complex abdominal wall hernia
|Hernia|2013|340
Diverse origins of the myofibroblast—implications for kidney fibrosis
|Nature Reviews Nephrology|2015|305
Strategies for encapsulation of small hydrophilic and amphiphilic drugs in PLGA microspheres: State-of-the-art and challenges
|International Journal of Pharmaceutics|2016|285